IRON TRIANGLE PARTNERS LP
Q4 2025 Form 13-F
COS COB, CONNECTICUT
CIK 0001779763
· CRD 302077
· SEC-registered investment adviser
$874.7M Reported Value Total
IRON TRIANGLE PARTNERS LP reports 7 total accounts under management (AUM). There are 7 discretionary accounts valued at $1,052,926,092, and 0 non-discretionary accounts.
Source: Form ADV filed * Note that certain holdings are exempt from Form 13-F reporting, so the AUM totals may be greater than the Form 13-F total.
SEC Registered
Discretionary Manager
Private funds (Form ADV)
2 funds
· $359.6M gross asset value
Hedge Fund: $359.6M
Source: Form ADV filed 2026-03-24
Reported value
$874.7M
Quarter over quarter
+19.8%
Holdings
27
Top-10 concentration
53.2%
Key People
Form ADV owners & control persons
Kevin Thomas Molloy
LIMITED PARTNER
Michael John O'Brien
CHIEF OPERATING OFFICER, CHIEF FINANCIAL OFFICER AND CHIEF COMPLIANCE OFFICER
Filing Navigation
13F Metrics
Loading 13F Metrics
Q4 2025 13F record
Q4 2025 13F filing summary
| Period of report | December 31, 2025 |
|---|---|
| Filed | February 17, 2026 |
| Form | 13F-HR |
| Reported value | $874.7M |
| Positions | 27 |
| Change in reported value | +24.4% |
| New positions | 16 |
| Exited positions | 14 |
| Position turnover | 73.2% |
| Top-10 concentration | 53.2% |
13F filings by quarter
| Quarter | Positions | Value |
|---|---|---|
|
Q4 2025 13F
Filed Feb 17, 2026
|
27 | $874.7M |
|
Q3 2025 13F
Filed Nov 14, 2025
|
25 | $703.3M |
|
Q2 2025 13F
Filed Aug 14, 2025
|
26 | $651.2M |
|
Q1 2025 13F
Filed May 15, 2025
|
27 | $634.4M |
|
Q4 2024 13F
Filed Feb 14, 2025
|
22 | $908.4M |
|
Q3 2024 13F
Filed Nov 14, 2024
|
24 | $721.8M |
|
Q2 2024 13F
Filed Aug 14, 2024
|
24 | $983.7M |
|
Q1 2024 13F
Filed May 15, 2024
|
28 | $976.3M |
|
Q4 2023 13F
Filed Feb 14, 2024
|
26 | $772.9M |
|
Q3 2023 13F
Filed Nov 14, 2023
|
23 | $684.2M |
|
Q2 2023 13F
Filed Aug 14, 2023
|
22 | $748.1M |
|
Q1 2023 13F
Filed May 15, 2023
|
27 | $693.2M |
|
Q4 2022 13F
Filed Feb 14, 2023
|
26 | $557.8M |
|
Q3 2022 13F
Filed Nov 14, 2022
|
27 | $572.0M |
|
Q2 2022 13F
Filed Aug 15, 2022
|
24 | $771.2M |
|
Q1 2022 13F
Filed May 16, 2022
|
28 | $840.7M |
|
Q4 2021 13F
Filed Feb 14, 2022
|
25 | $717.7M |
|
Q3 2021 13F
Filed Nov 15, 2021
|
26 | $696.8M |
|
Q2 2021 13F
Filed Aug 16, 2021
|
26 | $970.8M |
|
Q1 2021 13F
Filed May 17, 2021
|
27 | $786.5M |
5 earlier quarters on file — choose one from the quarter menu above.
Top 20 holdings · Q4 2025
| # | Holding | Reported value | % of portfolio |
|---|---|---|---|
| 1 | CRL CHARLES RIV LABS INTL INC | $75.7M | 8.66% |
| 2 | ISRG INTUITIVE SURGICAL INC | $53.5M | 6.12% |
| 3 | RGEN REPLIGEN CORP | $52.5M | 6.0% |
| 4 | JAZZ JAZZ PHARMACEUTICALS PLC | $49.7M | 5.68% |
| 5 | VCYT VERACYTE INC | $41.3M | 4.72% |
| 6 | BSX BOSTON SCIENTIFIC CORP | $40.1M | 4.59% |
| 7 | WAT WATERS CORP | $39.9M | 4.57% |
| 8 | BKD BROOKDALE SR LIVING INC | $37.7M | 4.31% |
| 9 | LLY ELI LILLY & CO | $37.7M | 4.31% |
| 10 | BRKR BRUKER CORP | $37.4M | 4.28% |
| 11 | VRTX VERTEX PHARMACEUTICALS INC | $34.9M | 3.99% |
| 12 | CVS CVS HEALTH CORP | $34.3M | 3.92% |
| 13 | FTRE FORTREA HLDGS INC | $34.3M | 3.92% |
| 14 | MMSI MERIT MED SYS INC | $34.0M | 3.89% |
| 15 | BTSG BRIGHTSPRING HEALTH SVCS INC | $33.6M | 3.84% |
| 16 | DOCS DOXIMITY INC | $30.4M | 3.48% |
| 17 | TECH BIO-TECHNE CORP | $27.5M | 3.14% |
| 18 | ATEC ALPHATEC HLDGS INC | $27.1M | 3.09% |
| 19 | AHCO ADAPTHEALTH CORP | $26.0M | 2.97% |
| 20 | NVST ENVISTA HOLDINGS CORPORATION | $25.8M | 2.95% |
Values as reported on the Q4 2025 Form 13F. Every position is in the holdings table below.